DalCor
is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cardiovascular disease... Read moreDalCor
is a Canada-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cardiovascular disease... Read more
CEO
Fouzia Laghrissi-Thode
News
Dec 30, 2024
Pharamceutical Technology
DalCor: Dalcetrapib by DalCor Pharmaceuticals for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Sep 21, 2023
FinSMEs
DalCor: DalCor Pharmaceuticals Closes USD80M Series D Financing
Sep 13, 2023
BioSpace
DalCor Pharmaceuticals: DalCor Pharmaceuticals announces Dal-GenE-2 confirmatory trial and closing of Series D financing round
Jul 21, 2022
FE Investegate
DalCor Pharmaceuticals: DalCor Pharmaceuticals : dal-GenE Phase 3 Cardiovascular Precision Medicine Outcomes Trial Results Published in European Heart Journal
Jan 11, 2021
GlobalNewswire
Press Release: DalCor Pharmaceuticals : DalCor Announces Launch of Dalcetrapib Clinical Trial for COVID-19
Jul 27, 2020
StreetInsider
Press Release: DalCor Pharmaceuticals : DalCor announces dal-GenE trial continues with final data expected in the first half of 2021
Jan 27, 2020
FE Investegate
DalCor Pharmaceuticals: DalCor Pharmaceuticals : DalCor announces dal-GenE trial to continue as planned following interim futility analysis
Mar 21, 2019
Genomeweb
DalCor Pharmaceuticals: Dalcor Holds Firm on Plans for Dalcetrapib Despite Negative Merck Results
Dec 17, 2018
FE Investegate
DalCor Pharmaceuticals: DalCor Pharmaceuticals : DalCor Announces Completion of Patient Enrollment in dal-GenE, the First Phase 3 Precision Medicine Cardiovascular Outcomes Trial in Coronary Heart Disease
Oct 16, 2018
BioPortfolio
DalCor Pharmaceuticals: DalCor Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250
DalCor Competitors
1
2
3
4
5
6
7
8
9
10